The U.S. targeted DNA RNA sequencing market size is calculated at USD 4.80 billion in 2025 and is forecasted to reach around USD 24.14 billion by 2034, accelerating at a CAGR of 19.63% from 2025 to 2034.The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: U.S. Targeted DNA RNA Sequencing Industry Impact
5.2. COVID-19 Impact Assessment for the Industry
5.3. COVID-19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. U.S. Targeted DNA RNA Sequencing Market, by Product
8.1.1. NGS
8.1.1.1. Market Revenue and Forecast
8.1.2. Application
8.1.2.1. Market Revenue and Forecast
8.1.3. Others
8.1.3.1. Market Revenue and Forecast
9.1. U.S. Targeted DNA RNA Sequencing Market, by Workflow
9.1.1. Pre-Sequencing
9.1.1.1. Market Revenue and Forecast
9.1.2. Sequencing
9.1.2.1. Market Revenue and Forecast
9.1.3. Data Analysis
9.1.3.1. Market Revenue and Forecast
10.1. U.S. Targeted DNA RNA Sequencing Market, by Type
10.1.1. DNA Based Targeted Sequencing
10.1.1.1. Market Revenue and Forecast
10.1.2. RNA Based Targeted Sequencing
10.1.2.1. Market Revenue and Forecast
11.1. U.S. Targeted DNA RNA Sequencing Market, by Application
11.1.1. Human Biomedical Research
11.1.1.1. Market Revenue and Forecast
11.1.2. Plant and Animal Sciences
11.1.2.1. Market Revenue and Forecast
11.1.3. Drug Discovery
11.1.3.1. Market Revenue and Forecast
11.1.4. Others
11.1.4.1. Market Revenue and Forecast
12.1. U.S. Targeted DNA RNA Sequencing Market, by End User
12.1.1. Academic Research
12.1.1.1. Market Revenue and Forecast
12.1.2. Hospitals and Clinics
12.1.2.1. Market Revenue and Forecast
12.1.3. Pharma and Biotech Entities
12.1.3.1. Market Revenue and Forecast
12.1.4. Others
12.1.4.1. Market Revenue and Forecast
13.1. North America
13.1.1. Market Revenue and Forecast, by Product
13.1.2. Market Revenue and Forecast, by Workflow
13.1.3. Market Revenue and Forecast, by Type
13.1.4. Market Revenue and Forecast, by Application
13.1.5. Market Revenue and Forecast, by End User
13.1.6. U.S.
13.1.6.1. Market Revenue and Forecast, by Product
13.1.6.2. Market Revenue and Forecast, by Workflow
13.1.6.3. Market Revenue and Forecast, by Type
13.1.6.4. Market Revenue and Forecast, by Application
13.1.6.5. Market Revenue and Forecast, by End User
13.1.7. Rest of North America
13.1.7.1. Market Revenue and Forecast, by Product
13.1.7.2. Market Revenue and Forecast, by Workflow
13.1.7.3. Market Revenue and Forecast, by Type
13.1.7.4. Market Revenue and Forecast, by Application
13.1.7.5. Market Revenue and Forecast, by End User
13.2. Europe
13.2.1. Market Revenue and Forecast, by Product
13.2.2. Market Revenue and Forecast, by Workflow
13.2.3. Market Revenue and Forecast, by Type
13.2.4. Market Revenue and Forecast, by Application
13.2.5. Market Revenue and Forecast, by End User
13.2.6. UK
13.2.6.1. Market Revenue and Forecast, by Product
13.2.6.2. Market Revenue and Forecast, by Workflow
13.2.6.3. Market Revenue and Forecast, by Type
13.2.7. Market Revenue and Forecast, by Application
13.2.8. Market Revenue and Forecast, by End User
13.2.9. Germany
13.2.9.1. Market Revenue and Forecast, by Product
13.2.9.2. Market Revenue and Forecast, by Workflow
13.2.9.3. Market Revenue and Forecast, by Type
13.2.10. Market Revenue and Forecast, by Application
13.2.11. Market Revenue and Forecast, by End User
13.2.12. France
13.2.12.1. Market Revenue and Forecast, by Product
13.2.12.2. Market Revenue and Forecast, by Workflow
13.2.12.3. Market Revenue and Forecast, by Type
13.2.12.4. Market Revenue and Forecast, by Application
13.2.13. Market Revenue and Forecast, by End User
13.2.14. Rest of Europe
13.2.14.1. Market Revenue and Forecast, by Product
13.2.14.2. Market Revenue and Forecast, by Workflow
13.2.14.3. Market Revenue and Forecast, by Type
13.2.14.4. Market Revenue and Forecast, by Application
13.2.15. Market Revenue and Forecast, by End User
13.3. APAC
13.3.1. Market Revenue and Forecast, by Product
13.3.2. Market Revenue and Forecast, by Workflow
13.3.3. Market Revenue and Forecast, by Type
13.3.4. Market Revenue and Forecast, by Application
13.3.5. Market Revenue and Forecast, by End User
13.3.6. India
13.3.6.1. Market Revenue and Forecast, by Product
13.3.6.2. Market Revenue and Forecast, by Workflow
13.3.6.3. Market Revenue and Forecast, by Type
13.3.6.4. Market Revenue and Forecast, by Application
13.3.7. Market Revenue and Forecast, by End User
13.3.8. China
13.3.8.1. Market Revenue and Forecast, by Product
13.3.8.2. Market Revenue and Forecast, by Workflow
13.3.8.3. Market Revenue and Forecast, by Type
13.3.8.4. Market Revenue and Forecast, by Application
13.3.9. Market Revenue and Forecast, by End User
13.3.10. Japan
13.3.10.1. Market Revenue and Forecast, by Product
13.3.10.2. Market Revenue and Forecast, by Workflow
13.3.10.3. Market Revenue and Forecast, by Type
13.3.10.4. Market Revenue and Forecast, by Application
13.3.10.5. Market Revenue and Forecast, by End User
13.3.11. Rest of APAC
13.3.11.1. Market Revenue and Forecast, by Product
13.3.11.2. Market Revenue and Forecast, by Workflow
13.3.11.3. Market Revenue and Forecast, by Type
13.3.11.4. Market Revenue and Forecast, by Application
13.3.11.5. Market Revenue and Forecast, by End User
13.4. MEA
13.4.1. Market Revenue and Forecast, by Product
13.4.2. Market Revenue and Forecast, by Workflow
13.4.3. Market Revenue and Forecast, by Type
13.4.4. Market Revenue and Forecast, by Application
13.4.5. Market Revenue and Forecast, by End User
13.4.6. GCC
13.4.6.1. Market Revenue and Forecast, by Product
13.4.6.2. Market Revenue and Forecast, by Workflow
13.4.6.3. Market Revenue and Forecast, by Type
13.4.6.4. Market Revenue and Forecast, by Application
13.4.7. Market Revenue and Forecast, by End User
13.4.8. North Africa
13.4.8.1. Market Revenue and Forecast, by Product
13.4.8.2. Market Revenue and Forecast, by Workflow
13.4.8.3. Market Revenue and Forecast, by Type
13.4.8.4. Market Revenue and Forecast, by Application
13.4.9. Market Revenue and Forecast, by End User
13.4.10. South Africa
13.4.10.1. Market Revenue and Forecast, by Product
13.4.10.2. Market Revenue and Forecast, by Workflow
13.4.10.3. Market Revenue and Forecast, by Type
13.4.10.4. Market Revenue and Forecast, by Application
13.4.10.5. Market Revenue and Forecast, by End User
13.4.11. Rest of MEA
13.4.11.1. Market Revenue and Forecast, by Product
13.4.11.2. Market Revenue and Forecast, by Workflow
13.4.11.3. Market Revenue and Forecast, by Type
13.4.11.4. Market Revenue and Forecast, by Application
13.4.11.5. Market Revenue and Forecast, by End User
13.5. Latin America
13.5.1. Market Revenue and Forecast, by Product
13.5.2. Market Revenue and Forecast, by Workflow
13.5.3. Market Revenue and Forecast, by Type
13.5.4. Market Revenue and Forecast, by Application
13.5.5. Market Revenue and Forecast, by End User
13.5.6. Brazil
13.5.6.1. Market Revenue and Forecast, by Product
13.5.6.2. Market Revenue and Forecast, by Workflow
13.5.6.3. Market Revenue and Forecast, by Type
13.5.6.4. Market Revenue and Forecast, by Application
13.5.7. Market Revenue and Forecast, by End User
13.5.8. Rest of LATAM
13.5.8.1. Market Revenue and Forecast, by Product
13.5.8.2. Market Revenue and Forecast, by Workflow
13.5.8.3. Market Revenue and Forecast, by Type
13.5.8.4. Market Revenue and Forecast, by Application
13.5.8.5. Market Revenue and Forecast, by End User
14.1. Bio-Rad Laboratories, Inc.
14.1.1. Company Overview
14.1.2. Product Offerings
14.1.3. Financial Performance
14.1.4. Recent Initiatives
14.2. Illumina, Inc.
14.2.1. Company Overview
14.2.2. Product Offerings
14.2.3. Financial Performance
14.2.4. Recent Initiatives
14.3. Thermo Fisher Scientific, Inc.
14.3.1. Company Overview
14.3.2. Product Offerings
14.3.3. Financial Performance
14.3.4. Recent Initiatives
14.4. PierianDx
14.4.1. Company Overview
14.4.2. Product Offerings
14.4.3. Financial Performance
14.4.4. Recent Initiatives
14.5. DNASTAR, Inc.
14.5.1. Company Overview
14.5.2. Product Offerings
14.5.3. Financial Performance
14.5.4. Recent Initiatives
14.6. Abbott PerkinElmer, Inc.
14.6.1. Company Overview
14.6.2. Product Offerings
14.6.3. Financial Performance
14.6.4. Recent Initiatives
15.1. Primary Research
15.2. Secondary Research
15.3. Assumptions
16.1. About Us
16.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
Plan your call and get expert insights!
Schedule a Meeting
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample